US FDA approves COVID-19 drug for young children
The US drug regulator on Monday granted the first full approval for treating COVID-19 in… Read More
The US drug regulator on Monday granted the first full approval for treating COVID-19 in… Read More
Owing to long queues, people are paying agents and locals ₹500 -₹1,500 to stand in… Read More
It was involved in refilling vials with glucose solution and sell it as Remdesivir injection Read More
"Gilead’s remdesivir is not recommended for patients hospitalised with COVID-19, regardless of how ill they… Read More
In a major relief to coronavirus patients, the Drug Regulatory Authority of Pakistan (DRAP) on… Read More
Shares of Gilead Sciences rose 6% on Friday after its antiviral drug, remdesivir, became the… Read More
Gilead's remdesivir was no better than a placebo at limiting severely ill patients' need for… Read More
Britain has rationed its supplies of the antiviral drug remdesivir and is prioritising COVID-19 patients… Read More
The federal government announced to reduce prices of key lifesaving drugs, including remdesivir, being used… Read More
A new study is raising fresh questions about the efficacy of Gilead Sciences' anti-viral medication… Read More
Drug Regulatory Authority of Pakistan (DRAP) has issued registration letters for import and manufacturing of… Read More
'FDA lately authorise the antiviral drug to treat coronavirus patients' Read More
European health regulator said it would look to fast-track the approval of this antiviral drug… Read More
Taiwan has been successful at preventing the coronavirus from spreading, thanks to early detection and… Read More
Gilead has pledged to donate 1.5 million doses of remdesivir - or enough to treat… Read More
The United States authorized the emergency use of remdesivir in hospitals on May 1, followed… Read More
A research team at the Institute Pasteur Korea have identified a drug that appears to… Read More
Dr Mirza said that an American company Gilead has given a voluntary licence to five… Read More
The pacts allow the companies - Jubilant Life Sciences, Cipla , Hetero Labs, Mylan NV… Read More
Japan reached the decision just three days after the U.S. drugmaker filed for fast-track approval… Read More